United States · FDA National Drug Code directory

Clorazepate Dipotassium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70954-159_d4edcb5d-dbe9-44c4-a0a9-d3b6aba4c22d
Product NDC: 70954-159
Form: TABLET
Composition / generic term: Clorazepate Dipotassium
Labeler: ANI Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20220616
Source listing expiry: 20261231

Source-listed ingredients

CLORAZEPATE DIPOTASSIUM — 3.75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (70954-159-10) · 70954-159-10
500 TABLET in 1 BOTTLE (70954-159-20) · 70954-159-20
30 TABLET in 1 BOTTLE (70954-159-30) · 70954-159-30
30 BLISTER PACK in 1 BOX, UNIT-DOSE (70954-159-50) / 1 TABLET in 1 BLISTER PACK (70954-159-40) · 70954-159-50

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →